J. Morgan Micheletti, MD, shared his pearls for beginning practice in comprehensive cataract ophthalmology in a presentation at the Real World Ophthalmology meeting.First, it is important to take your time, both in the clinic and in the operating room….
Month: September 2021
Finding Employees During a Pandemic
As private practices try to recover and rebuild in the wake of the COVID-19 pandemic, many have faced an unexpected challenge: a paucity of employees. Medscape Dermatology
Women ‘significantly underrepresented’ in medical journal editor positions
Among 410 leading medical journals, just 21% had a woman as editor in chief, according to findings published in JAMA Network Open.“Evidence on the gender gap in academia has been mounting over the past few years, and the gendered impact of COVID-19 may…
Global Synoptophore Markets 2021-2026 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Synoptophore Market – Growth, Trends, COVID-19 Impact, and Forecasts (2021 – 2026)” report has been added to ResearchAndMarkets.com’s offering. The synoptophore market is projected to register a CAGR of around 4% during th…
Anatomical, functional improvements seen with OpRegen in phase 1/2a study
Interim results from a study investigating OpRegen suggest a single treatment may provide improvements in patients with dry age-related macular degeneration with geographic atrophy, according to a Lineage Cell Therapeutics press release.OpRegen, an inv…
Glaukos Announces Licensing Agreement with Attillaps Holdings, Inc.
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced today that …
Aerie Pharmaceuticals Announces Appointment of Erik Pacyniak, Ph.D., D.A.B.T., as Director, Toxicology and Drug Disposition
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…
VIDEO: Proactive treatment of NPDR: What does the evidence say so far?
Should patients with nonproliferative diabetic retinopathy be treated early with prophylactic anti-VEGF therapy?At the virtual Euretina congress, Jennifer Sun, MD, MPH, speaks about the results of Protocol W and the PANORAMA trial and the questions tha…
VIDEO: Registries play key role in real-world evidence studies
In this video perspective from the virtual Euretina congress, Daniel Barthelmes, MD, PhD, speaks about the key role of registries in investigating treatment outcomes in real-world clinical practice.The Fight Retinal Blindness Registry has been an inval…
Poorer Teens Are More Likely to Have Lingering ‘Lazy Eye’
Researchers linked lower socioeconomic status and cognitive scores to higher rates of amblyopia, a condition that can become permanent if not treated early in childhood. Medscape Medical News
Gene Therapy Research Accelerates for Retinal Diseases
Patients who have rare retinal diseases — as well as those with more common ones — may benefit from a surge in gene therapy research. Medscape Medical News
Study shows success of hybrid in-person, telemedicine model of vitreoretinal care
A hybrid model of patient care, combining telemedicine and traditional face-to-face visits, may offer the best of both worlds, minimizing the risk for disease transmission while maximizing practicality and patient safety.“In a retrospective study, we a…
FDA: Avoid using certain Greenpark Compounding Pharmacy products
The FDA recommended health care providers and individuals avoid using compounded products said to be “sterile, produced and distributed nationwide by Prescription Labs Inc.” that does business as Greenpark Compounding Pharmacy.The agency based its reco…
Neurolens appoints Pierre Bertrand as CEO
Pierre Bertrand has been appointed as CEO of Neurolens, effective immediately, with current CEO and founder Davis Corley stepping into the role of executive chairman of the board of directors, according to a company press release.“I am honored and exci…
Global Dry Eye Treatment Devices Market Size, Share & Trends Analysis Report 2021-2028 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Dry Eye Treatment Devices Market 2021-2028” report has been added to ResearchAndMarkets.com’s offering. The global dry eye treatment devices market size is estimated to reach USD 414.2 million by 2028. It is anticip…
Common Eye Diseases Linked to Higher Risk for Dementia
The health of the retina may be a link to the health of the brain. Medscape Medical News
Optic Neuritis (Ophthalmology) Drugs Pipeline Guide 2021 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Optic Neuritis (Ophthalmology) – Drugs In Development, 2021” report has been added to ResearchAndMarkets.com’s offering. This report provides comprehensive information on the therapeutics under development for Optic Neurit…
Pegcetacoplan Shows Mixed Results for Geographic Atrophy
Two phase 3 trials yielded different results for pegcetacoplan as a treatment for geographic atrophy. Medscape Medical News
Global Eye Care Surgical Devices Market 2021-2025: High Incidence of Eye Diseases and growing Number of MI Glaucoma Surgeries Driving Growth – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Eye Care Surgical Devices Market 2021-2025” report has been added to ResearchAndMarkets.com’s offering. The eye care surgical devices market is poised to grow by $ 3.49 bn during 2021-2025, progressing at a CAGR of …
Griffey Eye Care, Center for Visual Surgical Excellence Join US Eye
CHESAPEAKE, Va.–(BUSINESS WIRE)– #Eyecare–Griffey Eye Care and the Center for Visual Surgical Excellence have joined the US Eye network of premium eye care practices.